Enliven Therapeutics, Inc.
Recent Filings
All 732 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 5,000 @ $16.84 | 897,688 | Dec 19, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 1,705 @ $21.78 | 263,311 | Dec 8, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 492 @ $23.09 | 902,688 | Nov 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,500 @ $21.82 | 890,392 | Nov 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 613 @ $17.94 | 269,974 | Nov 7, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 @ $22.08 | 915,188 | Oct 20, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,500 @ $21.33 | 902,892 | Oct 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,667 @ $20.10 | 276,641 | Oct 7, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 4,000 @ $20.25 | 927,688 | Sep 26, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 3,700 @ $20.06 | 915,392 | Sep 26, 2025 |